- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05103514
The Longitudinal Impact of SES and the CNDS on Recovery From SUD
April 11, 2024 updated by: Warren K. Bickel, Virginia Polytechnic Institute and State University
The Longitudinal Impact of Socioeconomic Status and the Competing Neurobehavioral Decision Systems on Recovery From Substance Use Disorder
The goal of this study is to provide a scientific understanding of the impact of socioeconomic status (SES) on the recovery trajectory (psychosocial functioning, relapse/remission status, and neurocognitive mechanisms).
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The study will characterize the effect of SES (subjective and objective indicators) on long-term trajectories of recovery and neurocognitive functioning.
By using an accelerated longitudinal design, the investigators will examine the association between baseline SES, changes in CNDS, and changes in psychosocial functioning (e.g., quality of life) and relapse.
Moreover, the investigators will use computational modeling to capture underlying changes in components of CNDS functioning related to SES and SUD recovery.
Study Type
Observational
Enrollment (Estimated)
675
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Warren K Bickel, PhD
- Phone Number: 540-526-2088
- Email: wkbickel@vt.edu
Study Contact Backup
- Name: Kirstin M Gatchalian
- Phone Number: 540-526-2071
- Email: kmgatch@vtc.vt.edu
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Individuals in recovery from SUD who meets the study inclusion criteria will be recruited from The International Quit & Recovery Registry (IQRR) (https://quitandrecovery.org).
Participants will be recruited from existing or new IQRR registrants; that is, IQRR registrants meeting the inclusion criteria (see above) will be invited to participate.
Also, the recruitment of new registrants will use methods designed to reflect the heterogeneity of the recovery population.
Description
Inclusion Criteria:
- be ≥18 yrs old
- meet lifetime DSM-5 SUD criteria
- have a Recovery Initiation Date less than 3 years prior to the time of enrollment
- be able to read independently
- be free of legal problems that could limit participation
- reside in the U.S.
- anticipate continued Internet access (to ensure ongoing contact and data collection)
- be a registrant of the International Quit and Recovery Registry (IQRR)
Exclusion Criteria:
- Minors will not be included
- Prisoners will not be included. If participants become incarcerated during this study, they will not be contacted to complete assessments during their incarceration. If the incarceration ends during the study, they may be contacted to participate in assessments.
- Adults who are not capable of consenting on their own behalf
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Cohort 1
Participants in this group started their recovery process < 1 year ago
|
There are no interventions planned for this study.
This is an observational study only.
|
Cohort 2
Participants in this group started their recovery process 1 to <2 years ago
|
There are no interventions planned for this study.
This is an observational study only.
|
Cohort 3
Participants in this group started their recovery process 2 to <3 years ago
|
There are no interventions planned for this study.
This is an observational study only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Socioeconomic Status (SES)- Individual Subjective SES
Time Frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Individual Subjective SES will be determined using the MacArthur Scale of subjective social status.
Participants will be presented with two social ladders that have 10 steps each and asked to place themselves on the rung that best represent where they stand at this time in their life (1=lowest rung and 10= highest rung), relative to other people in (1) the United States and (2) their community.
Higher scores on the 10-rung ladder indicate higher subjective SES.
|
Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Change in Socioeconomic Status (SES)- Individual Objective SES
Time Frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Individual Objective SES will be measured using a composite that was developed by the US Department of Justice (i.e.
National Crime Victimization Survey Index 1) that incorporates four main SES elements (i.e., income, education, employment status, and housing tenure measures).
Specifically, the SES composite index includes two individual level characteristics: education (possible range: 0-3) and employment in the last 6 months (possible range: 0-1); and two household level characteristics: income as a percentage of the federal poverty level (FPL; possible range: 0-3) and housing tenure (possible range: 0-1).
The final SES score (possible range: 0-8) is collapsed into three levels: low (total score of 0 to less than 3), middle (total score of 3 to less than 6), and upper (total score of 6-8) SES.
|
Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Change in CNDS functioning
Time Frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Delay Discounting (DD) task will be administered to assesses the value of delayed reinforcers.
Participants make hypothetical choices between amounts of delayed and immediate money at various delays (e.g., 1 day to 25 years)
|
Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Change in Psychosocial Functioning- The Psychosocial Functioning Inventory (PFI)
Time Frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
The Psychosocial Functioning Inventory (PFI) will be used to measure social functioning.
The social behavior sub-scale will be calculated from 10 items of the PFI and included items that assess the frequency of problematic social behavior and social interactions in the past 90 days.
The psychosocial functioning scale yields a score ranging from 0-100, with higher scores indicating greater impairment.
|
Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Change in Psychosocial Functioning- World Health Organization (WHO)-Quality of Life
Time Frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
WHO-Quality of Life brief assessment (BREF) will be used to measure the four domains of quality of life: (1) physical health; (2) psychological (3) social relationships; and (4) environment (26 items).
Each item in the WHOQOL-BREF will be scored with a 5-point Likert scale (three items are reverse scored), and these scores will be used to generate raw scores for each domain, which will be then scaled 0-100, with higher scores indicating greater quality of life.
|
Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Change in Psychosocial Functioning- Satisfaction with Life and social Functioning
Time Frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Satisfaction with life and social functioning over the past 90 days will be assessed using 4 questions: How happy have you been (1) with life?; (2) with your living situation?
and (3) with your relationships? and (4) Did you feel satisfied with leisure, social, and recreational activities?
(0 = satisfied/happy; 1 = dissatisfied/unhappy)
|
Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Change in Psychosocial Functioning- Career Engagement
Time Frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Engagement in proactive career behaviors over time (9 items).
Each item in the career engagement measure will be scored with the 5-point Likert-type scale.
The average scale scores will range between 1-5 with higher score indicating greater engagement.
|
Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Change in Psychosocial Functioning- Addiction Severity
Time Frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
The Addiction Severity Index (ASI) will be used to assess experiences of serious depression, serious anxiety or tension, and cognitive difficulty (i.e., trouble understanding, concentrating, or remembering) in the past 90 days.
All items will be binary indicators, where 0 = employed or symptom not present and 1 = unemployed or symptom present.
Items will be examined individually.
|
Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Change in Substance Use- SUD Status and Severity
Time Frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
The Diagnostic and Statistical Manual-5 (DSM-5) SUD (last year & last 3 months) will be used to assess SUD status and severity with mild, moderate, and severe sub-classifications
|
Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Change in Substance Use- Consumption
Time Frame: Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Timeline Follow Back-90 (TLFB-90) will be used to obtains retrospective daily estimates of substance use in the last 3 month.
TLFB can generate a variety of variables that provide more precise and varied information (e.g., pattern, variability) about a person's substance use
|
Approximately every 3 months from date of baseline session through study completion, an average of 3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Warren Bickel, PhD, Virginia Polytechnic Institute and State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
July 1, 2025
Primary Completion (Estimated)
April 1, 2028
Study Completion (Estimated)
July 1, 2028
Study Registration Dates
First Submitted
October 7, 2021
First Submitted That Met QC Criteria
October 20, 2021
First Posted (Actual)
November 2, 2021
Study Record Updates
Last Update Posted (Actual)
April 12, 2024
Last Update Submitted That Met QC Criteria
April 11, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SES- Longitudinal Study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorders
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of MichiganNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingSubstance Use | Substance Use Disorders | Substance DependenceUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Centre for Addiction and Mental HealthUniversity of Missouri, St. LouisCompletedSubstance Use Disorders | Alcohol Use DisorderCanada
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Opioid Use | Drug Use | Substance MisuseUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedPTSD | Alcohol Use Disorders | Substance Use DisordersUnited States
-
Istanbul UniversityCompletedSubstance Use | Substance Use Disorders | Substance AbuseTurkey
Clinical Trials on Online Survey
-
Tomsk National Research Medical Center of the Russian...RecruitingCOVID-19 | Risk Factors | Polypharmacy | Drug Interactions | Self MedicationRussian Federation
-
Jaseng Medical FoundationCompletedFractures, Bone | Medicine, Korean TraditionalKorea, Republic of
-
University of Wisconsin, MadisonNational Eye Institute (NEI)Not yet recruitingDiabetic RetinopathyUnited States
-
Addario Lung Cancer Medical InstituteUniversity of Southern California; Ohio State University Comprehensive Cancer...Recruiting
-
Imam Mohammad ibn Saud Islamic UniversityEnrolling by invitationForeign Bodies | Surgical Sponge, RetainedSaudi Arabia
-
Uskudar UniversityNew York Medical CollegeCompletedCOVID-19 | Stress | Anxiety | Mental Health Wellness 1 | Athlete | Life SatisfactionTurkey
-
University of ExtremaduraCompletedMental Health Wellness 1 | Sedentary BehaviorBrazil, Chile, Uruguay
-
Medical University of GrazRecruitingPsychological Distress | Corona Virus Infection | Psychiatric DisorderAustria
-
NYU Langone HealthCompleted
-
CHDI Foundation, Inc.IQVIA CompanyCompletedHuntington's DiseaseUnited States